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Background: The cell surface proteoglycans syndecan-1 and -4 interact with laminin 332 to participate in keratinocyte
migration.
Results: Syndecan-1 and -4 bind specific residues in the laminin 332 LG45 domain.
Conclusion:The LG45 domain encompasses a major heparan sulfate binding domain containing distinctive syndecan-1 and -4
binding sequences.
Significance: Identifying syndecan-1- and -4-binding sites in laminin 332 is crucial for elucidation of their function in kerati-
nocyte migration.
Keratinocyte migration during epidermal repair depends on
interactions between cellular heparan sulfate proteoglycan
receptors, syndecan-1 and -4, and the C-terminal globular
domains (LG45) of the extracellularmatrix protein laminin 332.
This study investigates the molecular basis of the binding spec-
ificity of the syndecan-1 and -4 receptors expressed by human
keratinocytes. We used site-directed mutagenesis to alter a
recombinant LG45 protein by substituting the most critical
basic residues with glutamine. All proteins were expressed in
mammalian cells, purified, and characterized biochemically.
We used in vitro binding assays, including surface plasmon res-
onance, to examine interactions between mutated LG45 and
heparan sulfates, syndecan-1 and -4. We identify a major hepa-
rin binding domain on the outer edge of a -strand of LG45
surrounded by a track of converging low affinity residues. This
domain harbors distinctive syndecan-1 and -4 binding-specific
sequences. This is the first study to demonstrate a binding spec-
ificity of two proteoglycans produced by a single cell type. In
addition, we found that although syndecan-1 interacts exclu-
sively through its glycosaminoglycan chains, syndecan-4 bind-
ing relies on both its core protein and its heparan sulfate chains.
These results suggest that LG45 may trigger different signals
toward keratinocytes depending on its interaction with synde-
can-1 or -4.
Cell adhesion to the extracellular matrix (ECM)3 stimulates
signal transduction cascades that are known to play critical reg-
ulatory roles in many biological processes, including wound
healing (1–3). Although integrins are the major cell surface
receptors for the ECM, transmembrane proteoglycans, such as
syndecans, compose an important class of adhesion receptors
that have recently attracted attention. Syndecans consist of
transmembrane core proteins that carry either heparan sulfate
(HS) orHS and chondroitin sulfate (CS) chains on their ectodo-
main. Through these chains, syndecans interact with growth
factors, cytokines, proteinases, other adhesion receptors and
ECM components. There are four syndecans in mammals,
which are expressed in a developmental cell type- and tissue-
specific manner (4, 5). Among numerous ligands within the
ECM, recent studies have shown that laminins (LNs) can inter-
act with these heparan sulfate proteoglycan (HSPG) receptors
to fulfill important cellular events (6).
LNs are large extracellular glycoproteins that are important
components of all basement membranes (BM), and they are
involved in several biological processes (7). All LNs are cross-
shaped heterotrimers composed of three different gene prod-
ucts, termed,, and  chains. Over 16 LN isoforms are known
with variable cell- and tissue-specific expression, and they are
differentially recognized by cellular receptors (8). Laminin 332
(LN332), composed of the 3,3, and 2 chains, is an epithelial
BM-specific variant. Its main role in normal tissues is themain-
tenance of epithelial-mesenchymal cohesion in tissues exposed
to external forces, including skin and stratified squamous
mucosa (9, 10). All LN  chains possess a large globular domain
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domains, each containing about 200 residues (LG1–5) (11). A
potential function for the tandem LG4-LG5 domains (LG45)
was initially suspected based on the ability of LN332 to trigger
distinct cellular events depending on the level of processing of
its 3 chain. A form of LN332 that lacked the LG45 was found
in mature BMs, where it was shown to play an important func-
tion in themaintenance of anchoring structures through integ-
rin interactions (12–14). In contrast, LN332 with an intact
LG45 was found in migratory/remodeling situations such as
epidermal repair (15–18). Recently, full-length LN332 (with
LG45) was proposed to be involved in the invasion of squamous
cell carcinomas in vivo (19).
Themechanismunderlying the function of the LG45 domain
in LN332 remains poorly understood. Several heparin binding
domains (HBD) were identified in the LG45 domain of the 3
chain (3LG45). These HBDs conferred heparin-dependent
cell adhesion properties, which suggested that this region in
LN332 could interact with an HSPG cellular receptor (20–22).
Later, a motif in the LG45 domain that included residues
1412NSFMALYLSKGR was shown to induce syndecan-2- and
-4-mediated cell adhesion, neurite outgrowth, and matrix met-
alloproteinase-1 and -9 secretion (23–26). Further work sug-
gested that this peptide motif also induced keratinocyte migra-
tion by triggering syndecan-4 clustering and subsequent 1
integrin activation (27). Others have reported that syndecan-1
was the cellular receptor involved in cell adhesion to the
3LG45 domain through its HS and CS chains (28, 29). This
interaction could drive keratinocyte migration by inducing the
formation of actin-based cellular protrusions and recruiting
syntenin-1 (30, 31). The first heparin/syndecan-binding sites
on LN332 were identified by peptide screening; however, a
more recent study identified three novel HBDs based on cross-
linking the native protein to heparin beads (22).
We wondered whether syndecan-1 and -4 interacted with a
unique or multiple sequences in the LN332 LG45 domain. To
address this question, we aimed to identify residues involved in
the interaction between cells and the 3LG45 domain and to
determine the molecular basis of the syndecan-1 and -4 inter-
action. By site-directed mutagenesis, we have identified the
syndecan-1- and -4-binding sites in the 3LG45 domain and
have demonstrated that these domains belong to a unique
HBD. We further showed that these two receptors bound spe-
cifically to overlapping but independent sites through different
mechanisms, in addition to the GAGs chains, as the core pro-
tein participates in syndecan-4 binding.
EXPERIMENTAL PROCEDURES
Cells and Antibodies—Fibrosarcoma HT1080 cells (CCL-
212, American Type Culture Collection) were cultured in Dul-
becco’s modified Eagle’s medium (DMEM) containing 2 mM
glutamine and 10% fetal calf serum. Normal human keratino-
cytes (NHK) cultures were established from foreskin in KBM-2
medium (Cambrex Bio-Sciences, Emerainville, Belgium) as
described previously (9). The human keratinocyte cell line
HaCat was grown in 50% Ham’s F-12 and 50% DMEM supple-
mented with 2 mM glutamine and 10% fetal calf serum. The
polyclonal antibody (pAb) against syndecan-1 was obtained by
rabbit immunization with the GST-syn-1 fusion protein (31);
the rabbit pAb H-174 against syndecan-1 was purchased from
Santa Cruz Biotechnology (Le Perray en Yvelines, France); the
rabbit pAb S9111-60 against syndecan-4 was purchased from
US Biologicals (distributed by Euromedex, Mundolsheim,
France), and the anti-HS F58-10E4 was from Seikagaku (dis-
tributed by AMS Biotechnology, Oxfordshire, UK). The pAb
against the LG45 fragment was described elsewhere (29).
Plasmids and Transfection—The human laminin 3LG45
domain (nucleotides 4057–5142) was generated by RT-PCR
amplification of poly(A) mRNA isolated from NHK with the
following primers: 5-GAATTCGAATTCGCTAGCTTGCT-
CACCACTTCCCAAGACCCAGGCC and 5-TCTAGATCT-
AGATGCGGCCGCCTGGTCAGGACAACCATTCAGACT-
GAC. The resulting PCR product of 1080 bp was restriction-
digested with NotI and NheI and inserted in-frame with
sequences that encoded the BM-40 signal peptide and the six-
histidine tag in the mammalian expression vector pCEP-Pu
(32). Site-directed mutagenesis was performed on the LG45
sequence to substitute the lysine and arginine residues (single,
double, or triple, as indicated in Fig. 1) to glutamine. This was
accomplished by PCR amplification with oligonucleotides that
contained themutation sequences. Themutated PCR products
were cloned into pCEP-Pu. All inserts and borders were fully
sequenced (Genome Express, Meylan, France). These vectors
were stably transfected into 293-EBNA cells (Invitrogen) with
the FuGENE 6 reagent (Roche Diagnostics). Transfected cells
were selected with 0.5 g/ml puromycin and grown to conflu-
ence. Conditioned medium samples from transfected and wild
type cells were analyzed with SDS-PAGE to confirm the secre-
tion of WT and mutated recombinant LG45-His6 fusion pep-
tides into the medium.
Fusion proteins between GST and the human syndecan-1
and -4 ectodomains (GST-hS1ED and GST-hS4ED, respec-
tively) were produced as followed. To append the ectodomain
of syndecan-1 (Gln-18 to Gln-232) and syndecan-4 (Glu-19 to
Phe-141) to the C terminus of GST, the cDNA encoding these
domains was amplified by PCR, subcloned into EcoRI and NotI
sites of pGEX-4T3 (GE Healthcare), and sequenced. GST
fusion proteins were then produced in bacteria and purified on
glutathione-Sepharose 4B beads (GE Healthcare) or 96-well
glutathione-chelate plates (Nunc, Dutscher, Brumath, France)
as recommended by the manufacturer’s instructions.
Purification and Heparin Binding Assay for Recombinant
LG45 Fragments—The recombinant LG45 proteins were
secreted by transfected 293-EBNA cells cultured in serum-free
DMEM.The conditionedmediumwas collected every 48 h, and
50 M N-ethylmaleimide and 50 M phenylmethanesulfonyl
fluoride were added. To purify the His6-tagged LG45 proteins,
conditioned medium was mixed with imidazole (10 mM) and
salt (0.3 MNaCl) and applied to 5-ml nickel/nitrilotriacetic acid
columns (Ni-NTA Superflow Cartridge, Qiagen, Coutaboeuf,
France). After washingwith 50mMNaH2PO4, 300mMNaCl, 20
mM imidazole, proteins were eluted with a linear gradient of
20–400 mM imidazole. SDS-PAGE analysis showed an esti-
mated protein purity of 90%. Protein concentration was
determined with the bicinchoninic acid assay (Pierce). To eval-
uate protein affinity for heparin, LG45-His6 proteins were
placed in a 1-ml HiTrap heparin column (GE Healthcare) in
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0.02 M Tris-HCl, pH 7.4, followed by elution with a linear gra-
dient of 0–1 M NaCl. All the collected fractions were further
analyzed by SDS-PAGE followed by Coomassie staining.
Cell Adhesion Assays—LG45 peptides were immobilized
on multiwell nickel-chelate plates (Nunc). To ensure equal
amounts and identical orientations of all immobilized proteins,
multiwell plates were coated with serial dilutions of LG45 sub-
strates in 0.01 M KCl and allowed to adsorb overnight at 4 °C.
Plates were washed with PBS and saturated with 1% BSA. Next,
HT1080 cells were prepared by detaching with 5 mM EDTA/
PBS, followed by rinsing and suspending in serum-free medi-
um; cells were seeded on LG45-coated plates at 8  104 cells/
well. After 30 min, nonadherent cells were removed with a PBS
wash. The extent of adhesion was determined by fixing adher-
ent cells and then staining with 0.1% crystal violet and mea-
suring absorbance at 570 nm as described previously (33). A
blank value was subtracted that corresponded to BSA-coated
wells. Each assay point was derived from triplicate measure-
ments S.D. (three wells per assay point). Adherent cells were
photographedwith anAxiovert 40 Zeissmicroscope coupled to
a Coolsnap Fx Camera (Roper Scientific, Evry, France), and 100
cells (with or without protrusions) were counted in each well.
The amount of adsorbed protein was determined with a BCA
microprotein assay.
Time Lapse Video Microscopy—NHKs were seeded at 104
cells/well in 24-well plates in KBM-2 medium that contained
eitherWTormutated LG45-His6 (20g/ml). Cell behaviorwas
monitored at 37 °C for 24 h in a humidified atmosphere con-
taining 5% CO2 with an Axiovert 100 M Zeiss microscope
equipped with a CCD camera (one picture every 20 min). In
each experiment, we analyzedmovements of 80–100 cells with
tracking software (Metaview; Roper Scientific, Princeton
Instruments, Evry, France). The maximal relative distances to
origin (MRDO), defined as the linear distance between the orig-
inal position of the cell and the farthest position of the cell (34),
were determined.
Syndecan-1 and -4 Binding Assays—HaCat, NHK, or
HT1080 cells were extractedwith cold RIPA lysis buffer (20mM
Tris-HCl, pH 7.4, 150 mM NaCl, 2 mM EDTA, 250 M phenyl-
methylsulfonyl fluoride, 1 mM N-ethylmaleimide, 1% Nonidet
P-40, 1% Triton X-100, 0.1% sodium deoxycholate, 0.1% SDS).
All the following procedures were performed at 4 °C. After cen-
trifugation, lysate protein concentrationswere determined, and
equivalent amounts of proteins were tested in either ELISA-
based syndecan-1 and -4 binding assays or affinity precipitation
experiments. The ELISA-based assay was performed with
96-well nickel-chelate plates, coated with WT or mutated
LG45-His6, as described above. After plateswere saturatedwith
1%BSA for 4 h at 4 °C, cell lysates were added (300g/well) and
incubated overnight at 4 °C. After washes with lysis buffer and
PBS, plates were incubated for 3 hwith anti-syndecan-1 or anti-
syndecan-4 pAbs. The plates were then washed with PBS and
incubated with appropriate FITC-conjugated secondary anti-
bodies (Jackson ImmunoResearch) for 1 h. After PBS washes,
50 l of 20 mM NH4OH with Triton 0.5% was added to each
well, and fluorescence intensity was determined at 485–535 nm
with a VICTORX4 Technologies reader (PerkinElmer Life Sci-
ences). A blank value corresponding to BSA-coated wells was
systematically subtracted, and each assay point was derived
from triplicate measurements. In case of pretreatment with
heparitinase I, cells were incubated in digestion buffer (20 mM
sodium acetate, pH 7.0, 5 mM CaCl2) with or without 8 milli-
units/ml heparitinase I (Seikagaku America, Coger, Paris,
France) for 4 h at 25 °C prior to the lysis in RIPA buffer.
For syndecan-1 and -4 pulldown experiments, 100g ofWT
or mutated LG45-His6 proteins were linked to nickel magnetic
beads (Millipore SAS,Molsheim, France) for 2 h at 4 °C in incu-
bation buffer (50 mM NaH2PO4, pH 8, 300 mM NaCl). Next,
beadswerewashed in incubation buffer, followed by incubation
with 1 mg of cell lysis extract, supplemented with 10 mM imid-
azole for 2 h. Beads were thenwashed in lysis buffer with 20mM
imidazole and incubated in digestion buffer with 8 milli-
units/ml heparitinase I and 50 milliunits/ml chondroitinase
ABC for 2 h at 25 °C. Proteins were resolved on 8 or 10% SDS-
polyacrylamide gels. Separated proteins were transferred to
nitrocellulose, followed by immunodetection of syndecan-1 or
syndecan-4 by enhanced chemiluminescence.
GST-syndecan-1 and -4 ectodomains were immobilized on
multiwell glutathione-chelate plates (Nunc). The wells were
blocked with 4% milk in PBS and incubated with soluble LG45
(10 g/ml) for 4 h at 22 °C. They were further exposed (1 h,
22 °C) to a constant amount of anti-LG45 pAb, and detection
was performed using FITC-conjugated antibodies as described
above.
Circular Dichroism (CD) Spectroscopy—CD spectra were
recorded on an Aviv Model 215 instrument (Aviv Biomedical
Inc., Lakewood, NJ; 1-nm bandwidth, 0.2-nm steps, 3–5 s per
point accumulation time) equipped with a thermostatted cell
holder. Buffer baselines were recorded in the same cell and
subtracted. Data were smoothed and normalized to mean resi-
due ellipticities []MRW. Samples were dialyzed into 200 mM
NaF, 20 mM NaH2PO4/NaOH, pH 7.2. Full spectra (260 to
180 nm; dynode voltage 500 V) were collected at protein
concentrations of 0.5 mg/ml in a 0.02-cm quartz cuvette at
4 °C. Concentrations were determined by absorption at 280
nm, assuming an extinction coefficient of 280 	 25,940 M
1
cm
1, based on the amino acid composition (35). CD spectra
were deconvoluted to determine secondary structure content
with the CDsstr algorithm (36), as implemented in the
Dichroweb server (37)with the reference data sets SP175 (190–
260 nm) (38) and 3 (185–260 nm) (39). Thermal transition
curves were constructed from spectra recorded in a 0.1-cm cell
(protein concentration 0.1 mg/ml) at various temperatures
between 4 and 85 °C upon stepwise heating. Ellipticities []
observed at 200, 207, and 218 nm as a function of temperature
were normalized to the fraction of folded protein, F 	 ([] 

[]u)/([]n
 []u), where []n and []u represent signals for
the fully folded and fully unfolded species, respectively. Data
were fitted assuming a two-state transition (40) with the melt-
ing temperature, Tm, defined as F(Tm)	 0.5.
Surface Plasmon Resonance (SPR)-based Binding Assay—
Real time binding analyses were performed on a Biacore 3000
apparatus, operated by a Biacore 3000 control software 4.1 ver-
sion (Biacore Sweden). HS (average mass 	 15 kDa; Celsus
Laboratories; Cincinnati, OH) was biotinylated at the reducing
end, as described previously (41), and immobilized on a CM4
Syndecan-1 and -4 Binding to Laminin3LG45
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Biacore sensorchip. Briefly, two flow cells were activated with
50 l of 0.2 M N-ethyl-N-(diethylaminopropyl)-carbodiimide
and 0.05 M N-hydroxysuccinimide. Next, 50 l of streptavidin
(Sigma) at 0.2 mg/ml in 10 mM sodium acetate buffer, pH 4.2,
was injected. The remaining activated groups were blocked
with 50 l of 1 M ethanolamine, pH 8.5. Typically, this proce-
dure allowed coupling of2500 response units of streptavidin
on both flow cells. BiotinylatedHS (15g/ml)was then injected
over one surface (until achieving a level of 50 response units),
and the other surface remained untreated to serve as a negative
control. Before use, the chipwas submitted to several injections
of 2 M NaCl and washed in a continuous flow of 10 mM Hepes,
pH 7.4, 0.15 M NaCl, 0.05% P20 detergent. For binding assays,
WT ormutant 3LG45was injected over both negative control
andHS surfaces for 5min at 25 °C at a rate of 50l/min. TheHS
surface was regenerated with a 1-min pulse of 0.05% SDS fol-
lowed by a 2-min pulse of 2 M NaCl. Apparent dissociation
constants were estimated by fitting the steady state values at
equilibrium Req(c) assuming one or two binding sites with
Req(c)	 Reqmax/(KD c) and Req(c)	 Reqmax1/(KD1 c) Reqmax2/
(KD2 c), respectively.
Molecular Modeling—A three-dimensional model of the
3LG45 domain pair was generated with ProMod II (Version
3.70 SP3 (42)). The x-ray derived coordinates of mouse LN 1
LG45 (Protein Data Bank code 2JD4, chain B (43)) served as a
template. After optimizing the alignmentmanually, a final total
energy of
7025 kJ/mol was achieved.
RESULTS
Production and Purification of Recombinant 3LG45-His6
Proteins—The 3LG45 fragment was produced as described
previously (29) except that a His6 tag was added at the C termi-
nus. Transfected human embryonic kidney 293-EBNA cells
secreted LG45-His6 protein into the culture medium. We
tested the effect of the His6 tag on the ability of recombinant
LG45-His6 to bind heparin. As shown in Fig. 1A, the protein
was captured on heparin-Sepharose beads and was released
with 1MNaCl buffer. Purificationwas based onHis6 tag binding
to Ni-NTA-conjugated beads, followed by elution with an
imidazole buffer. SDS-PAGE analysis of untagged and His6-
tagged LG45 proteins revealed a slight difference in the migra-
tion of the two proteins (Fig. 1B).
To test whether specific arginine and lysine residues in the
3LG45 domains are involved in heparin and syndecan binding
(Fig. 1C), we substituted these charged residueswith glutamine.
The side chain volume and hydrophilicity are more closely
related to the basic residues than the alanine typically used in
substitution studies (43–46). First, we designed a series of sin-
gle or doublemutant proteins (Fig. 1D,mutants 1–12). Thenwe
designed a second series that included triple mutants (mutants
13–18). Residues were selected based on sequence alignments
among homologous human LN isoforms. We mutated all resi-
dues that were shown to participate in heparin binding in the
1 chains (43, 44) and 4 chains (46). Residues Lys-1387 and
Arg-1389 weremutated (mutant 1), because the corresponding
residues in the 1 and 2 chains have been shown to be
involved in syndecan-1 binding (47). Lys-1421 (mutant 4) and
Arg-1423 (mutant 5) weremutated because these residues have
previously been shown to affect heparin and cell binding based
on a synthetic peptide approach (24), although the Lys-1421
residue is substituted with acidic residues in the mouse and rat
3 chains. Double and triple mutant proteins 13 and 14 cover
simultaneous mutations of the lysine residues within the syn-
thetic peptide A3G75aR reported as responsible for synde-
can-2- and -4-mediated cell binding activity (23). Finally, Arg-
1436, Lys-1438, Lys-1497, and Lys-1613 (located in LG5), were
mutated because these were identified as heparin-binding res-
idues in a study where native 3LG45 was cross-linked to hep-
arin beads, and the sequences involved were characterized (22).
WT LG45 and all mutated LG45 proteins were expressed in
293-EBNA cells and secreted into the culture medium. They
were purified usingNi2-chelated beads. Eachmutated protein
migrated as a major band, displayed a molecular mass equiva-
lent to that of WT, and gave a strong signal when probed in
immunoblots with the anti-LG45 pAb (Fig. 1D).
3LG45 and Mutant Protein Binding to Heparin and HS—
The binding properties of WT and mutated LG45 were tested
on a heparinHitrap column.We startedwith low ionic strength
to determine the NaCl concentrations required for displace-
ment (Table 1). As the His6 tag did not affect the heparin bind-
ing properties of LG45, this system was suitable for testing the
properties of mutant LG45 proteins. The analysis of proteins
1–14, including single, double, and triple mutants (Fig. 1D),
revealed that twoproteins carrying a singlemutation (Arg-1436
or Lys-1438) eluted from the column at a much lower ionic
strength (0.48 M NaCl) than the WT 3LG45 (0.65 M NaCl).
This suggested that this sequencemight harbor amajor binding
site. Four mutants behaved identically to the WT protein, but
six other mutants eluted at 0.6 M NaCl suggesting that addi-
tional residues may also participate, to a lesser extent, in GAG
interactions. Combiningmutations of two or three of these low
binding residues (mutants 13 and 14, Fig. 1D) only slightly
modified the ionic strength to 0.55 M NaCl. Therefore, a series
of double and triple mutants was designed to target the
sequence 1433KKLRIKSKEK, which harbors residues Arg-1436
and Lys-1438 (Fig. 1D, lower panel). These mutants displayed
severe defects in heparin binding.When both theArg-1436 and
Lys-1438 residues were mutated, the defect in heparin binding
was only moderately intensified, 0.44 M NaCl being necessary
for elution. When a neighboring residue, Lys-1434, was
mutated, the mutant protein eluted at 0.54 M NaCl. When all
three residues were combined, Lys-1434/Arg-1436/Lys-1438,
the mutant eluted at a NaCl concentration of only 0.41 M. In
contrast, another combination mutant, Arg-1436/Lys-1438/
Lys-1440, eluted at the same NaCl concentration required for
eluting theArg-1436/Lys-1438mutant. These data suggest that
the residues Lys-1434, Arg-1436, and Lys-1438 were critical for
heparin binding of the LG45 domain. As the binding to heparin
was not fully abolished with any of the mutated LG45 proteins,
we used SPR spectroscopy to analyze the WT and mutated
LG45 interactions with HS. First, we determined the affinity of
WT LG45 for HS using biotinylated HS immobilized on a
streptavidin-coated sensor chip. This system mimicked to
some extent cell membrane-anchored HSPG. We injected a
range of concentrations (8.7–100 nM) of LG45 tomeasure bind-
ing (Fig. 2A). The association phase (from 150 to 450 s) was
Syndecan-1 and -4 Binding to Laminin3LG45
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allowed to proceed to equilibrium. Both the association and
dissociation (t 450 s) kinetics indicate a complex interaction
mechanism with a fast phase followed by a slower one, which is
especially obvious by the long time required to reach base-line
levels after protein injection stopped. This behavior probably
reflects the heterogeneity of the HS preparation with respect to
length and sulfation pattern. To reduce bias in deriving affinity
data from rate constants, we focused on establishing steady
state values at equilibrium. Req as a function of protein concen-
trationwas fitted assuming one or two binding sites resulting in
high affinity dissociation constants of10 and6 nM, respec-
tively, indicating that WT LG45 displayed a strong affinity for
HS (Fig. 2B).
The same assay was used to determine the HS binding
strength of the different LG45 mutants (Fig. 2C). We injected
WTormutant LG45 proteins (all at 13 nM) over theHS surface.
The binding responses of themutants were comparedwith that
of WT LG45. The binding to HS was slightly different as com-
pared with that observed with heparin (Fig. 2C). Although only
two mutated LG45s showed affinity equivalent to theWT, sev-
FIGURE 1. Recombinant 3LG45-His6 proteins. A, left panel, 2 ml of serum-free, 293-EBNA-conditioned cell culture medium (lane 1) were mixed with
heparin-Sepharose beads and analyzed for its content of LG45-His6 (lane 2). Proteins were eluted with 100l of 0.02 M Tris-HCl, pH 7.4, 1 M NaCl (lane 3). Right
panel, serum-free, 293-EBNA-conditionedcell culturemedium (lane1)wasmixedwithNi-NTA-conjugatedbeadsandanalyzed for its contentof LG45-His6 (lane
2). Proteinswere elutedwith 100l of PBSwith 200mM imidazole (lane 3). All samples (20l) were separatedby12%SDS-PAGEunder reducing conditions, and
blotswereprobedwith thepAbLG45.B, comparisonof recombinant untagged LG45 (lanes 1) and LG45-His6 (lanes 2) proteins visualizedbyCoomassie Brilliant
Blue R-250 (2g) or immunoblotting (0.15g) with pAb LG45. The position of a 37-kDamolecular massmarker is shown on the right. C, amino acid sequence
of the WT 3LG45-His6 recombinant fragment; residues substituted with glutamine in the mutants are shown in bold and underlined. D, WT and mutated
recombinant 3LG45-His6 proteins (single, double, and triple mutations as indicated on the left) were expressed in 293 EBNA cells and purified with Ni
2-
chelated beads. Purified proteinswere analyzedby SDS-PAGE and either stainedwith Coomassie Blue or immunoblottedwith the anti-LG45pAb, as indicated.
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eral mutants showed a 20–35% affinity decrease. Among these,
K1411Q, K1421Q, and R1423Q mutants displayed equivalent
binding to HS even when they were combined. In contrast with
the heparin binding studies, the Lys-1440/Lys-1442 mutant
showed a 50% decrease in binding to HS. The three Lys-1434,
Arg-1436, and Lys-1438 mutants each displayed an equivalent
60% binding that dropped to 10% when mutated Arg-1436 and
Lys-1438 were combined confirming the importance of these
residues. The two triplemutants, Lys-1434/Arg-1436/Lys-1438
and Arg-1436/Lys-1438/Lys-1440, failed to bind to HS, con-
firming that LG45 encompasses a unique major site for HS
binding.
Structure and Stability of 3LG45 andMutant Proteins—To
ensure that mutations did not impact on heparin binding
through incorrect protein folding, all protein variantswere ana-
lyzed by CD spectroscopy. Far-UV CD spectra were recorded
for wild type 3LG45 and all mutant fragments (Fig. 3A).
Within the 260 to 190-nm range, all spectra were identical
within experimental error. No significant changes were
observed between 4 and 45 °C. The spectra showed a character-
isticminimumat 218nmandmaxima at 201 and 189nm,which
was consistent with data reported for the proteolytically
derived fragment E3 frommouse tumor laminin-111 that com-
prised the 1LG45 domains (48). Deconvolution of the spectra
showed that the -helix and -strand contents were 2–4 and
40–44%, respectively. This agreed with the 1.2% -helix and
46.9%-sheet contents found for the x-ray-derived structure of
the mouse 1LG45 domain pair (Protein Data Bank code 2JD4,
see Ref. 43). When heated above 45 °C, the CD signal indicated
unfolding of the LG45 domains (Fig. 3B), which was not revers-
ible upon cooling. Assuming a two-state transition, data fitting
resulted in apparent melting temperatures between 57.5 and
59.2 °C. The CD spectra and the thermal stability indicated that
3LG45 and all mutant proteins had very similar conforma-
tions consistent with the x-ray-derived structures of laminin
LG domains (43, 45, 49).
3LG45 and Mutant Protein Binding to Syndecan-1 and -4—
We previously showed that cell adhesion to the 3LG45 frag-
ment relies on the HSPG receptor syndecan-1 without involve-
ment of syndecan-4 (29, 30). In several cell types, including
FIGURE 2. SPR analysis of HS binding to WT and mutated LG45-His6.
A, series of sensorgrams showing the binding of different concentrations of
theWT LG45 to immobilized HS. LG45 concentrations of (from top to bottom)
100, 66, 44, 30, 20, 13, and 8.7 nM were injected for 5 min over control and
HS-activated surfaces at a flow rate of 50 l/min. The response (in response
units) was recorded as a function of time. Control sensorgrams were sub-
tracted from HS sensorgrams. B, equilibrium binding data Req as function of
concentration. Req are the steady state values at equilibrium recorded at the
end of the association phase, and c indicates the concentrations of injected
3LG45.Dotted anddashed lines represent fittingof thedata assumingoneor
two binding sites with KD 	 9.6  0.6 nM (r
2 	 0.991, 2 	 124), and KD1 	
6.1 1.6 and KD2	 110 13 nM (r
2	 0.999, 2	 17), respectively. Experi-
ments were performed in triplicate. C, WT and mutant LG45 protein (13 nM)
binding responses recorded at the end of the injection phase. The results
(means of three experiments S.D.) are expressed as thepercentagebinding
relative to the WT response (100%).
TABLE 1
Mapping of ligand-binding sites on 3LG45 bymutagenesis
Values are the mean of three independent determinations.
Laminin 3 LG45 mutant
Heparin bindinga
(M NaCl)
Syndecan-1
bindingb
Syndecan-4
bindingc
Wild type 0.65d 1.00 1.00
K1387Q/R1389Q 0.65 0.97 0.94
R1402Q 0.60 1.05 1.02
K1411Q 0.60 1.01 1.12
K1421Q 0.60 1.02 1.09
R1423Q 0.60 1.03 0.92
K1421Q/R1423Q 0.55 0.98 1.01
K1411Q/K1421Q/R1423Q 0.55 0.97 0.95
K1433Q 0.65 0.98 1.06
R1436Q 0.48 0.71 0.80
K1438Q 0.48 0.73 0.72
K1440Q/K1442Q 0.60 0.94 0.21
K1497Q 0.60 0.98 1.15
K1516Q 0.65 1.04 0.93
K1613Q 0.65 1.02 0.94
K1434Q 0.54 0.83 0.87
R1436Q/K1438Q 0.44 0.45 0.34
K1434Q/R1436Q/K1438Q 0.41 0.07 0.23
R1436Q/K1438Q/K1440Q 0.44 0.26 0.02
a Concentration of NaCl required for elution from a heparin affinity column equil-
ibrated in 0.02 M Tris-HCl, pH 7.4.
b As determined by solid phase assay with antibodies against syndecan-1 and rela-
tive to wild type binding.
c As determined by solid phase assay with antibodies against syndecan-4 and rela-
tive to wild type binding.
d Untagged LG45 required 0.65 M NaCl for elution from heparin.
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NHKandHT1080 cells, the syndecan-1 receptor induced, in an
integrin-independent manner, the formation of filopodium-
like protrusions (29–31). We therefore used this model to
investigate whether the various mutations could affect the syn-
decan-1 interaction. Cell adhesion assays were performed with
HT1080 cells as these cells are more easily dissociated from
culture plates with EDTA.We found that the different heparin
affinities of 3LG45 proteins correlated well with syndecan-1-
mediated cell adhesion. HT1080 cells displayed similar adhe-
sion when placed on WT LG45 and all mutant LG45 proteins
that required either 0.65, 0.6, or 0.55 MNaCl concentrations for
elution from heparin (Fig. 4A). Only cell adhesion to the Arg-
1436 and Lys-1438 mutants (0.48 M NaCl) was decreased. The
analysis of cell phenotypes (Fig. 4B) revealed that cells plated on
all mutants, except Arg-1436 and Lys-1438 mutants, spread
and formed protrusions in a manner comparable with cells
plated on the WT protein (60–70% of adhered HT1080 cells
developed microspikes). The cells plated on Arg-1436 and Lys-
1438 mutants failed to form protrusions (only 2% of adhered
cells developed protrusions) and were clustered in aggregates.
We then performed a dose-response analysis of cell adhesion to
the mutants that targeted the sequence 1433KKLRIKSKEK (Fig.
4C). This confirmed that Lys-1434, Arg-1436, and Lys-1438
were crucial for syndecan-1-mediated cell adhesion, and pro-
trusion elongation required residues Arg-1436 or Lys-1438.
Indeed, the single Lys-1434 mutant displayed reduced cell
adhesion, equivalent to that observed with the Arg-1436 and
Lys-1438 mutants, but Lys-1434 also formed protrusions. Cells
failed to adhere to the Lys-1434/Arg-1436/Lys-1438 triple
mutant at all concentrations tested. Moderate but equivalent
adhesion was obtained with either the Arg-1436/Lys-1438 or
Arg-1436/Lys-438/Lys-1440 mutants. This suggests that the
Lys-1440 residue mutation did not affect -mediated cell
adhesion.
As other studies have shown that syndecan-4 can interact
with 3LG45 (23, 24), we investigated whether syndecan-1 and
-4 extracted from cell lysates can interact with LG45 through
the same binding site. First, we used solid phase assays to test
WT andmutated LG45 proteins immobilized on nickel-chelate
plates with solubilized syndecan-1 and -4 derived from human
keratinocyte (HaCat) cells that express significant amounts of
syndecan-1 and -4 (Table 1) (29). The first series of mutants
(mutants 1–14, Fig. 1) revealed that both Arg-1436 and Lys-
1438 mutants displayed a 20–30% reduced affinity for synde-
can-1 and -4. In contrast, all the other mutants were compara-
blewithWTLG45 in binding syndecan-1 and -4.Unexpectedly,
the Lys-1440/Lys-1442 mutant was deficient in syndecan-4
binding as a residual 20% interaction could be detected. The
second series of mutants (mutants 15–18, Fig. 1) revealed that
syndecan-1 failed to bind the Lys-1434/Arg-1436/Lys-1438
mutant, which confirmed our syndecan-1-mediated HT1080
cell adhesion data. Interestingly, syndecan-4 moderately inter-
acted with the Lys-1434/Arg-1436/Lys-1438 mutant, but failed
to bind to the Arg-1436/Lys-1438/Lys-1440 mutant. These
results suggest that, although Lys-1440 was apparently not
essential for syndecan-1 binding, it was critical for syndecan-4
binding. We tested this hypothesis by affinity precipitation
(pulldown) experiments (Fig. 5, A and B). HaCat cell lysates
were mixed with nickel magnetic beads coated with WT or
mutated LG45 proteins. Beads were subjected to heparitinase/
chondroitinase ABC treatment, and gel sample buffer was
added to the samples prior to their electrophoresis analysis so
that all bound syndecan-1 and -4 could be detected. Western
blot analysis revealed bands that corresponded to syndecan-1
or syndecan-4 (Fig. 5A) core proteins in the material bound to
the WT and mutant LG45 proteins. Consistent with the solid
phase assays, the Arg-1436/Lys-1438 mutant showed impor-
tant defects in both syndecan-1 and syndecan-4 binding; syn-
decan-1 failed to interact with the Lys-1434/Arg-1436/Lys-
1438 mutant, whereas syndecan-4 failed to bind the Arg-1436/
Lys-1438/Lys-1440 mutant. The experiment was repeated
using NHK and HT1080 cells (Fig. 5B) with the most relevant
mutated LG45 proteins and produced similar results. These
results show that syndecan-1 and syndecan-4 share a common
FIGURE 3. CD spectra and thermal stability of 3LG45 WT and mutant
proteins. A, far-UV CD spectra were recorded at 4 °C for the protein samples
(numbers indicated on the right correspond to those shown in Fig. 1D). Spec-
tra were staggered by successive addition of500 degrees cm2 dmol
1, i.e.
the signal at 260 nm is around zero for all proteins. B, thermal transition
curves were derived from full spectra. Data points represent themean values
of the degree of folded protein F, as defined under “Experimental Proce-
dures,” observed at 200, 207, and 218 nm. Lines represent fits assuming a
two-state transition. To facilitate comparisons, data are staggered by 0.2
units.
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binding site that includes residues Arg-1436 and Lys-1438 in
LG45.
Syndecan-4 Binding to LG45 Involves Both HS and the Core
Protein—The LG45/syndecan-1 interaction was previously
shown to rely exclusively on GAGs with a participation of both
HS and CS (29). To study the mechanism of syndecan-4/LG45
binding, intact as well as HS-free GAGs from cells were com-
pared to reveal the role of HS in syndecan-4 binding (Fig. 5C).
NHK and HT1080 cells were either untreated or treated with
heparitinase I to degrade HS. WT and mutated LG45 proteins
immobilized on nickel-chelate plates were incubated with sol-
ubilized intact or enzyme-treated cell lysates, and bound syn-
decan-4 was detected by ELISA. Treatment of the cells with
heparitinase I only partially prevented interaction of the synde-
can-4 with LG45 suggesting another binding mechanism.
Although HS digest only moderately decreased syndecan-4
interaction with the tested mutants, it completely abrogated
the residual interaction observed with the Lys-1440/Lys-1442
mutant. As shown in Fig. 5C (right panel), heparitinase I digest
was efficient as HS were not detected in the heparitinase
I-treated lysates. To further evaluate the binding of the synde-
can-1 and -4 core proteins to LG45, we produced fusion pro-
teins between GST and the human syndecan-1 and -4 ectodo-
mains (GST-hS1ED and GST-hS4ED respectively). The fusion
proteins were purified on glutathione-Sepharose beads and
analyzed by SDS-PAGE followed by Coomassie Blue staining
(Fig. 5D). The GST-hS1ED and GST-hS4ED were then immo-
bilized on glutathione plates and tested for their ability to inter-
act with soluble LG45 protein. As shown in Fig. 5D, LG45 was
detected only in wells coated with GST-hS4ED reinforcing the
FIGURE 4. Cell adhesion onWT andmutated3LG45.Mutated LG45 proteins were analyzed for their capacity to induce syndecan-1-mediated HT1080 cell
adhesion. The extent of cell adhesionwasmeasuredwith a colorimetric assay as described under “Experimental Procedures” and expressed as a percentage of
the total cell adhesion observedonWTLG45. Data are representative of three independent experiments.A,multiwell Ni2-chelate plateswere coatedwithWT
and mutated LG45 (0.2 g). HT1080 cells that expressed syndecan-1 receptors were seeded (8  104 cells/well) onto the plates and incubated for 30 min.
B, phase contrastmicrographs showmorphology of cells that adhered toWT and LG45mutants. Photographswere taken after 30min incubation. Bar, 50m.
C,multiwell nickel-chelate plates were coated with WT and LG45 proteins specifically mutated in the targeted Lys-1434 to Lys-1440 region. HT1080 cells that
expressed syndecan-1 receptor were seeded (8 104 cells/well) onto the plates and incubated for 30 min.
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hypothesis that the syndecan-4 core protein participates in the
binding to LG45.
Effect of WT and Mutant LG45 on Keratinocyte Migration—
A study reported that LG45 could stimulate NHK migration
when added to the culture through amechanism involving syn-
decan-4 (26, 27). Therefore, we tested whether mutation in the
syndecan-4-binding site could affect this phenomenon. We
directly assessed the migratory behavior of NHKs by monitor-
ing cell migration for 8 h with a time-lapse video recorder. The
individual cell tracks (Fig. 6A) showed marked differences in
behavior when WT 3LG45 was absent or present in the cul-
turemedium.Maximal relative distances to the originmeasure-
ments revealed that 80% of cells plated in the absence of LG45
covered distances less than 50 m; in contrast, 65% of cells
plated with WT LG45 covered 50–200 m (n	 100 cells, p
0.001; Fig. 6B). Interestingly, the mutant protein deficient in
syndecan-4 binding (Arg-1436/Lys-1438/Lys-1440) failed to
trigger NHK motility. These results confirm previous findings
showing that soluble LG45 stimulate NHK migration and fur-
ther show that residues Arg-1436/Lys-1438/Lys-1440 are
involved in this phenomenon.
DISCUSSION
Unique HS Binding Domain within 3LG45 Harbors Specific
Syndecan-1- and -4-binding Sites—This study demonstrates
that the 3LG45 domain of LN332 harbors a major HS bind-
ing region (1433KKLRIKSKEK) that was different from any
sequences previously identified through synthetic peptide
screening (20, 23, 50). Thus, in this case, short peptides could
not reproduce the structural conformation assumed by this
region within the full-length protein. Interestingly, the
sequence identified in this study was identical to one of the
threeHBDs identified byVivès et al. (22).Weperformed amore
detailed analysis, which revealed that three critical residues
(Lys-1434, Arg-1436, and Lys-1438) were involved in synde-
can-1 interaction. In addition, we found that syndecan-4 could
bind a region in LG45 that was different from that recognized
by syndecan-1. A mutant encompassing residues Lys-1440 and
Lys-1442 displayed major defects in syndecan-4 interaction
suggesting an important role for this region, and we suggest
that this region may encompass the syndecan-4 core protein
binding domain. We further showed that Arg-1436, Lys-1438,
and Lys-1440 are the key residues involved in the syndecan-4
interaction. Taken together, our results show that syndecan-1
and syndecan-4 bind to distinct but overlapping sites, with a
common region including residues Arg-1436 and Lys-1438.
Each site contains additional specific residues located N- or
C-terminal to these two central residues.
Specific residues involved in heparin, dystroglycan, synde-
can, and calcium binding have been identified by site-directed
mutagenesis for the LG4 or LG45 domains of the laminin 1,
2, and 4 chains and corroborated by x-ray structural analysis
for1 and2 (43–46).Our results show that the cluster of basic
residues (Lys-1434 to Lys-1438) in 3LG4 that were responsi-
ble for heparin and syndecan-1 and -4 binding (Table 1) corre-
spond to similar clusters identified in the1 and4 chains (Fig.
7A). The 2 chain has no basic residues within this sequence
region. Instead, the 2LG5, rather than the 2LG4, domain
FIGURE 5. Syndecan-1 and -4 binding to WT and mutated 3LG45 pro-
teins. A and B, HaCat, NHK, and HT1080 cell lysates were incubated with
beads coated with WT or mutated LG45 proteins as indicated. Uncoated
beadswere used as a control. After washing, beadswere digestedwith hepa-
ritinase I and chondroitinase ABC and prepared for electrophoresis analysis.
The bound material was analyzed on an 8 or 10% SDS-polyacrylamide gel
under reducing conditions followed by immunoblotting with the pAb H-174
against syndecan-1or apAbagainst syndecan-4 as indicated.A,HaCat lysates
were incubated with beads covered with each individual mutated LG45 pro-
tein; B, NHK and HT1080 lysates were incubated with selected LG45 mutants
as indicated. Themigration positions ofmolecular weightmarkers are shown
on the left. The data are representative of three independent experiments.
C, effect of GAGs on syndecan-4 binding to WT and mutated LG45 proteins.
NHK (left panel) and HT1080 cells (right panel) were collected from culture
plates in digestion buffer, followed by treatment with (gray bars) or without
(black bars) 8 milliunits/ml heparitinase I for 4 h at 25 °C. After treatment, cell
extracts were lysed in RIPA buffer, and syndecan-4 ELISA-based assays were
performed with 96-well nickel-chelate plates, coated with WT or mutated
LG45-His6, as described under “Experimental Procedures.” Results are
expressed as a percent of syndecan-4 interaction with the WT LG45 in the
absence of enzyme treatment. Right panel, nitrocellulose containing BSA and
lysates of heparitinase I-treated and untreated -NHK and HT1080 cells (1 g)
were immunoblotted with the anti-HS F58–10E4 mAb. D, left panel, sche-
matic representation of the GST-fused human syndecan-1 and -4 ectodo-
mains. Central panel, 15% SDS-PAGE analysis followed by Coomassie Blue
staining of 0.5 g of each GST fusion protein, including the GST alone (as
indicated).Right panel,GST-fusionproteinswere coupled toglutathione-che-
late 96-well plates and incubated with soluble LG45. After washes, bound
LG45 was detected as described under “Experimental Procedures.”
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appears to be responsible for heparin binding (49, 51). Lysine
and arginine residues are also found in the equivalent positions
of the3 chains ofmouse, rat, chicken, and frog (Xenopus tropi-
calis). Mutations of Lys-1440 and Lys-1442 had no significant
effect on the binding to heparin or syndecan-1 but led to mark-
edly reduced binding to syndecan-4 (Table 1). The 4LG4
lysine residue, which corresponds to Lys-1442 (Fig. 7A), was
partially involved in heparin binding, but the mutant was not
tested for syndecan interactions (see Table 1 in 46). For known
3 chains, including rat, mouse, chicken, and frog, residues in
the position equivalent to Lys-1442, but not Lys-1440, are
either lysine or arginine, which indicates potential functional
importance.
Syndecan-1 and -4 Binding Domains Are Juxtaposed and
Both Accessible—A homology-based structural model of the
human3LG45 domainswith themouse1LG45 crystal struc-
ture as a template (43) showed that the residues involved in
heparin binding were located on the outer edge of -strand G
(see nomenclature accompanying Ref. 49), although residues
involved in syndecan-4 binding were within the adjacent loop
that connects strands G and H (Fig. 7B). Strand G forms the
outer edge of the concave -sheet of the -sandwich structure.
We identified an additional group of mutants that also contrib-
uted to heparin binding as they were eluted at 0.6 M NaCl. SPR
analysis of the interactions between thesemutants andHS con-
firmed these findings and identified Arg-1402, Lys-1411, Lys-
1421, Arg-1423, and Lys-1497 as low GAG affinity residues.
The structural model suggests that the concave surface of the
-sheet might act as a groove to align GAG chains along low
affinity residues and direct them toward Arg-1436 and Lys-
1438. A surface view of this structure (Fig. 7C) shows that the
NH2 groups of the basic residues involved in heparin and syn-
decan binding are accessible.
In addition to site-directedmutagenesis studies of the LNLG
domains (43–46, 49), short synthetic peptide studies have
elucidated heparin- and syndecan-binding sites. Peptide
A3G75aR, which harbored residues 1412NSFMALYLSKGR of
human 3LG45, was found to bind to heparin and promote cell
adhesion through syndecan-2 and -4 (23). Another report
described a heparin-binding synthetic peptide 1399KPRLQF-
SLDIQT of the mouse 3LG4 sequence corresponding to resi-
dues 1387–1398 of human 3LG4 (Fig. 1C) (20). We made
mutant 3LG45 proteins that had substitutions of Lys-1387/
Arg-1389, Lys-1421, or Arg-1423 with glutamine; however,
these showed no effects on syndecan-1 or -4 binding (Table 1
and Fig. 5). Similar discrepancies between alternative ap-
proaches were also found for HBDs within the LG domains of
the 1, 2, and 4 LN chains (cf. Fig. 7A with Fig. 7 of Ref. 52).
This probably indicates that binding required a specific spatial
arrangement of the functional amino acid side chains, which
cannot be adopted within a short peptide.
This study reveals that the GAG chains of syndecan-1 and -4
expressed by NHK interact with specific residues in LG45. It
shows that residuesArg-1436/Lys-1438 participate in both syn-
decan-1 and -4 binding, although residues Lys-1434 and Lys-
1440 are specific for binding to syndecan-1 and -4, respectively.
This is the first study to demonstrate this type of specificity in
syndecan binding in any LN or other ECM protein. It has long
been suspected that specific sulfation patterns are required for
specific HS/ligand interactions, and the overall structure of the
FIGURE 6. Effect ofWT andmutated3LG45 proteins on keratinocytemigration. A,NHKs were seeded at 104 cells/well in KBM-2medium alone (control)
or KBM-2 medium that contained either WT or mutated LG45-His6 (20 g/ml). Cell migration was recorded at 20-min intervals over a period of 8 h. In each
condition, the cell migratory plot shows positions for 15 cells in one field, oriented to place the cell origins at x(0), y(0). The distance migrated in micrometers
is indicated on the axes. B, histograms of maximal relative distances to origin data for 100 cells in each condition. Total data corresponding to migrated
distances were compared with the Student’s t test (*, p 0.001 between control and WT LG45 and between WT and R1436Q/K1438Q/K1440Q).
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HS was reported to be of importance (53). We have not inves-
tigated whether the specificity observed depends on the GAG
compositions or their sulfation levels in this study. Future anal-
ysis will be carried out to determine the molecular basis of the
glycosaminoglycan interaction specificity. In addition, our data
showing binding of the syndecan-4 core protein to the laminin
3LG45 are novel. This interaction is likely to contribute to the
syndecan-4-specific interaction. These findings corroborate
previous studies showing the involvement of the core protein in
syndecan-4 interaction and function (54, 55).
Specific Syndecan-1 and -4 Interactions with 3LG45 May
Trigger Specific Cellular Responses—Numerous studies have
indicated that the LG45 domain of the human LN332 3 chain
plays an important role in controlling cellular behavior, and it is
believed to interact with HSPG cellular receptors, either in an
immobilized or soluble manner. In normal conditions, after
secretion and deposition in the BM, LN332 rapidly undergoes
specific processing, including the cleavage of its LG45 domain.
This cleavage allows the first three LG1–3 domains to bind
integrins and support biological activities in epithelial BMs (33,
56, 57). Some studies have revealed that the LG45 domain can
function both in the full-length LN332 molecule and after it is
processed and released.When syndecan-1was allowed to inter-
act with immobilized LG45 either alone orwithin pre-LN332, it
induced the formation of protrusive adhesion structures
through activation of Rac and Cdc42 GTPases (30). Our cell
adhesion experiments revealed that Lys-1434, Arg-1436, and
Lys-1438 residues are required for syndecan-1-mediated cell
adhesion and Arg-1436 or Lys-1438 for protrusion elongation
(Fig. 4). We previously showed that syndecan-4 is not involved
in this mechanism (30), and we confirmed here that residues
specific for the syndecan-4 interaction (Lys-1440/ Lys-1442)
were not involved in syndecan-1-mediated cell adhesion.Other
in vitro studies reported that adding either recombinant
3LG45 or LG4 to the culture medium could induce migration
of NHK (26). It was further suggested that this migration
depended on a specific sequence within LG4 (1412NSFMALYL-
SKGR; see Ref. 23). We have confirmed that the WT LG45
domain induces keratinocyte motility, and we have shown that
this property is dependent on the syndecan-4 binding domain.
These results reinforce previous data that LG45 had a specific
syndecan-4-dependent mobilizing effect (27). In contrast to
that study attributing the effect to 1412NSFMALYLSKGR based
on synthetic peptides, we found that in native 3LG45, this
property is carried by residues 1436RIKSKEK.
FIGURE 7. Sequence/structure relation of amino acid residues that inter-
act with heparin and syndecans. A, human LN 3LG4 sequence (residues
1362–1534) was aligned to that of mouse LN 1LG4 (residues 2718–2898;
accession number P19137), LN 2LG4 (residues 2755–2934; accession num-
berQ60675), and LN4LG4 (residues 1457–1636; accessionnumber P97927).
Residues that diminished heparin binding activity when mutated to gluta-
mine (3) or alanine (1, 2, and 4), are shown in white on a black back-
ground. Other basic residues that could bemutatedwith no significant effect
onheparinbindingare shown inboldandunderlined. Residues in the3chain
that affected syndecan-4, but not heparin binding, are highlighted in green.
Aspartic acid residues involved in Ca2 binding are highlighted in purple. All
cysteine residues are highlighted in yellow. Mutation data were reproduced
from previous studies for the 1 (43, 44), 2 (45), and 4 chains (46). The
assignment to -strands A–N (boxed), using the nomenclature of Tisi et al.
(49), was based onmolecular modeling. B,molecular model of the secondary
structure of the 3LG45 domain pair. The three disulfide bonds formed by
cysteines 1354–1617, 1507–1530, and 1682–1710 are shown in yellow. Resi-
dues mutated in this study are depicted in ball-and-stick representations: red
and blue indicate residues with and without effects on heparin binding,
respectively; green indicates residues involved in syndecan-4 interactions.
C, electrostatic surface potential is represented in the same orientation and
on the same scale as in B, and negative and positive potentials are shown in
red and blue, respectively. Residues shown in B are rendered here in space-
fillingCPKmodels, with the same color-codingused in B. A probe radius of 1.4
Å was applied.
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In this study, we have identified syndecan-1- and -4-binding
sites in the 3LG45 domain of LN332. Our results provide the
first evidence that specific residues in 3LG45 interact with
each of these syndecans. Several lines of evidence have sug-
gested that LG45 is connected to LN332 in the ECM during
wound repair (12, 16, 58, 59). LG45 in full-length LN332 was
shown to play a central role in the polarization andmigration of
cells (18, 60) and syndecan-1 binding to LG45 was shown to
support keratinocyte migration over immobilized full-length
LN332 (29, 30). Moreover, the LG45 region has also been dem-
onstrated to function in the deposition and/or retention of full-
length LN332 in the ECM (19, 61, 62). The identification of the
syndecan-1- and -4-binding sites in the LN332 LG45 domain is
a first step toward understanding of the function of these syn-
decans in keratinocyte biology.
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